HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intestinal metaplasia subtyping: evaluation of Gomori's aldehyde fuchsin for routine diagnostic use.

AbstractAIMS:
Intestinal metaplasia (IM) has been implicated in the pathogenesis of gastro-oesophageal carcinoma, but because of its common occurrence, its specificity for use in cancer surveillance is low. IM subtypes characterized by mucin phenotype have been studied to try and improve specificity.
METHODS AND RESULTS:
On balance, type III IM seems the most promising for use in gastric cancer surveillance. The situation is problematic at the gastro-oesophageal junction where the normal occurrence of acidic mucins raises doubt on the value of subtyping. High iron diamine-Alcian blue combination (HID-AB) is commonly used for IM subtyping, but its potential toxicity and long staining period (up to 24 hours) precludes widespread clinical use. This study has compared the sulphomucin staining ability of Gomori's aldehyde fuchsin-Alcian blue combination (GAF-AB) against HID-AB for identifying and subtyping IM in gastric and oesophageal biopsies.
CONCLUSIONS:
Compared to HID-AB, a sensitivity of 85%, a specificity of 100% and a staining time of less than 30 minutes, shows this stain to be a simple and effective technique for identifying and subtyping IM in routine laboratories.
AuthorsK A Shah, A J Deacon, P Dunscombe, A B Price
JournalHistopathology (Histopathology) Vol. 31 Issue 3 Pg. 277-83 (Sep 1997) ISSN: 0309-0167 [Print] England
PMID9354900 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Rosaniline Dyes
Topics
  • Biopsy
  • Esophagus (pathology)
  • Evaluation Studies as Topic
  • Histocytochemistry (methods)
  • Humans
  • Intestines (pathology)
  • Metaplasia (classification, diagnosis)
  • Rosaniline Dyes
  • Sensitivity and Specificity
  • Staining and Labeling (methods)
  • Stomach (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: